Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « AffRegion.i » - entrée « Auvergne-Rhône-Alpes »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Auvergne (région administrative) < Auvergne-Rhône-Alpes < Bade-Wurtemberg  Facettes :

List of bibliographic references indexed by Auvergne-Rhône-Alpes

Number of relevant bibliographic references: 30.
[0-20] [0 - 20][0 - 30][20-29][20-40]
Ident.Authors (with country if any)Title
000104 (2021) Farah Daou [Liban] ; Gretta Abou-Sleymane [Liban] ; Danielle A. Badro [Liban] ; Nagham Khanafer [France] ; Mansour Tobaiqy [Arabie saoudite] ; Achraf Al Faraj [Liban]The History, Efficacy, and Safety of Potential Therapeutics: A Narrative Overview of the Complex Life of COVID-19.
000202 (2021) Van Thu Nguyen [France] ; Philippe Rivière [France] ; Pierre Ripoll [France] ; Julien Barnier [France] ; Romain Vuillemot [France] ; Gabriel Ferrand [France] ; Sarah Cohen-Boulakia [France] ; Philippe Ravaud [France] ; Isabelle Boutron [France]Research response to coronavirus disease 2019 needed better coordination and collaboration: a living mapping of registered trials.
000225 (2021) Alexis Lacout [France] ; Pierre Yves Marcy [France] ; Christian Perronne [France]Re: 'Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al.
000226 (2021) Minh Patrick Lê [France] ; Nathan Peiffer-Smadja [France] ; Jeremie Guedj [France] ; Nadège Neant [France] ; France Mentré [France] ; Florence Ader [France] ; Yazdan Yazdanpanah [France] ; Gilles Peytavin [France]Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial-authors' response.
000434 (2021) Alexis Lacout [France] ; Christian Perronne [France] ; Valere Lounnas [Allemagne]Hydroxychloroquine in Hospitalized Patients with Covid-19.
000573 (2021) Martin Cour [France] ; Camille Amaz [France] ; Julien Bohé [France] ; Thomas Rimmelé [France] ; Michel Ovize [France] ; Laurent Argaud [France]Day-90 survival in critically-ill patients with COVID-19 and hydroxychloroquine: a propensity analysis.
000639 (2021) Amin Gasmi [France] ; Massimiliano Peana [Italie] ; Sadaf Noor [Pakistan] ; Roman Lysiuk [Ukraine] ; Alain Menzel [Luxembourg (pays)] ; Asma Gasmi Benahmed [France] ; Geir Bj Rklund [Norvège]Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story.
000711 (2021) Hervé Seligmann [Allemagne]Balanced evaluation of preliminary data on a candidate COVID-19 hydroxychloroquine treatment.
000716 (2021) Anick Bérard [Canada, France] ; Odile Sheehy [Canada] ; Jin-Ping Zhao [Canada] ; Evelyne Vinet [Canada] ; Caroline Quach [Canada] ; Behrouz Kassai [France] ; Sasha Bernatsky [Canada]Available medications used as potential therapeutics for COVID-19: What are the known safety profiles in pregnancy.
000881 (2020) M. Roustit [France] ; R. Guilhaumou [France] ; M. Molimard [France] ; M-D Drici [France] ; S. Laporte [France] ; J-L Montastruc [France]Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence.
000883 (2020) Lucile Grange [France] ; Philippe Guilpain [France] ; Marie-Elise Truchetet [France] ; Jean-Luc Cracowski [France]Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A review.
000984 (2020) Cédric Annweiler [Canada] ; Bérangère Hanotte [France] ; Claire Grandin De L'Eprevier [France] ; Jean-Marc Sabatier [France] ; Ludovic Lafaie [France] ; Thomas Célarier [France]Vitamin D and survival in COVID-19 patients: A quasi-experimental study.
000A05 (2020) Frederic Sacher [France] ; Laurent Fauchier [France] ; Serge Boveda [France] ; Christian De Chillou [France] ; Pascal Defaye [France] ; Jean Claude Deharo [France] ; Estelle Gandjbakhch [France] ; Vincent Probst [France] ; Ariel Cohen [France] ; Christophe Leclercq [France]Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection.
000A57 (2020) Sophie Perinel [France] ; Manon Launay [France] ; Élisabeth Botelho-Nevers [France] ; Éric Diconne [France] ; Aurore Louf-Durier [France] ; Raphaël Lachand [France] ; Martin Murgier [France] ; Dominique Page [France] ; Régine Vermesch [France] ; Guillaume Thierry [France] ; Xavier Delavenne [France]Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients.
000B74 (2020) Anne-Lise Bienvenu [France] ; Aileen M. Marty [États-Unis] ; Malcolm K. Jones [Australie] ; Stephane Picot [France]Systematic review of registered trials of Hydroxychloroquine prophylaxis for COVID-19 health-care workers at the first third of 2020.
000D65 (2020) Nicolas Vedrines [France] ; Anne-Typhaine Bouthors [France] ; Stéphane Gayet [France] ; Alexis Lacout [France]Re: Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis' by Fiolet et al.
000D67 (2020) Minh Patrick Lê [France] ; Nathan Peiffer-Smadja [France] ; Jeremie Guedj [France] ; Nadège Néant [France] ; France Mentré [France] ; Florence Ader [France] ; Yazdan Yazdanpanah [France] ; Gilles Peytavin [France]Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial.
000D83 (2020) Sarah Grewal [États-Unis] ; Lior Jankelson [États-Unis] ; Marcel P H. Van Den Broek [Pays-Bas] ; Martin Cour [France] ; Gloria Bachmann [États-Unis] ; John B. Kostis [États-Unis] ; Kamana Misra [États-Unis]QTc Prolongation Risk Evaluation in Female COVID-19 Patients Undergoing Chloroquine and Hydroxychloroquine With/Without Azithromycin Treatment.
000D97 (2020) Florence Ader [France]Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults.
000E40 (2020) Florian Lemaitre [France] ; Caroline Solas [France] ; Matthieu Grégoire [France] ; Laurence Lagarce [France] ; Laure Elens [Belgique] ; Elisabeth Polard [France] ; Béatrice Saint-Salvi [France] ; Agnès Sommet [France] ; Michel Tod [France] ; Chantal Barin-Le Guellec [France]Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments.
001007 (2020) Matthias Jacquet-Lagrèze [France] ; Zakaria Riad [France] ; Elisabeth Hugon-Vallet [France] ; Arnaud Ferraris [France] ; Jean-Luc Fellahi [France]Left ventricular dysfunction in COVID-19: A diagnostic issue.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AffRegion.i -k "Auvergne-Rhône-Alpes" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AffRegion.i  \
                -Sk "Auvergne-Rhône-Alpes" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AffRegion.i
   |clé=    Auvergne-Rhône-Alpes
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021